Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer
Study Information
Alliance Study ID: NCCTG-N0322
NCT Study ID (ClinicalTrials.gov): NCT00104754
Disease or Cancer Type: Lung Cancer & Mesothelioma
Alliance Study Chair: James R. Jett, MD
Status: WITHDRAWN
Study Description
RATIONALE: Drugs used in chemotherapy, such as liposomal SN-38, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This phase II trial is studying how well liposomal SN-38 works in treating patients with small cell lung cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information